Although COVID-19 has drawn away the focus of the healthcare industry from other pressing matters, there are some issues that need to be addressed immediately, and the cost of prescription drugs is one of them. Even though companies hire pharmacy benefit managers to devise patient-friendly plans for their customers, they fail to help patients in affording medication.
Today, Capital Rx has become the leader in the movement to make drug pricing transparent and help patients reap the maximum benefits of their health plans. This is why the company has managed to secure a follow-on funding of $50 million from Edison Partners, a business growth company that has previously invested $12 million into the pharmacy benefit manager.
Read the full article here: Edison Partners: Ethical & Transparent Drug Pricing